Osiris Therapeutics, Miasole, PicoChip, and more
New hopes for combating the disease
Apple sees greater risk in staying with IBM's chips than in aligning itself with Intel.
Entergy Nuclear treads carefully in proposing a new nuclear power plant.
Why TiVo has never turned a profit.
A humble man from West Virginia known for his honesty and integrity, Charles M. Vest has led MIT for the last 14 years. On the brink of his departure, he reflects on his presidency and some of the pivotal decisions that have altered the course of the Institute.
A new production method could ensure an ample vaccine supply during the flu season.
Returning to campus